Fernando Bermejo

7PUBLICATIONS
19CO-AUTHORS
Immunogenetics (incl. genetic immunology)Cancer therapy (excl. chemotherapy and radiation therapy)Rheumatology and arthritisApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Nephrology and urology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 03, 2023
Serum and Urine Metabolomic Profiling of Newly Diagnosed Treatment-Naïve Inflammatory Bowel Disease Patients.

Laila Aldars-García, Rubén Gil-Redondo, Nieves Embade

|Jul 31, 2023
Comparative Study of the Effectiveness of Vedolizumab Versus Ustekinumab After Anti-TNF Failure in Crohn's Disease (Versus-CD): Data from the ENEIDA Registry.

María José García, Montserrat Rivero, Agnès Fernández-Clotet

|Feb 15, 2022
Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease Patients: The SUSTAIN Study.

María Chaparro, Iria Baston-Rey, Estela Fernández-Salgado

|Oct 12, 2021
Corrigendum to: Re-induction With Intravenous Ustekinumab in Patients With Crohn's Disease and a Loss of Response to This Therapy.

Fernando Bermejo, Laura Jiménez, Alicia Algaba

|Apr 16, 2021
Effectiveness and Safety of Ustekinumab in Ulcerative Colitis: Real-world Evidence from the ENEIDA Registry.

María Chaparro, Ana Garre, Marisa Iborra

Pageof 2